Published in J Virol on May 23, 2007
Viral quasispecies evolution. Microbiol Mol Biol Rev (2012) 2.69
Mechanisms of viral emergence. Vet Res (2010) 1.25
Enhanced mucosal immunoglobulin A response and solid protection against foot-and-mouth disease virus challenge induced by a novel dendrimeric peptide. J Virol (2008) 0.97
Expression and stability of foreign epitopes introduced into 3A nonstructural protein of foot-and-mouth disease virus. PLoS One (2012) 0.88
A single amino acid substitution in the capsid of foot-and-mouth disease virus can increase acid lability and confer resistance to acid-dependent uncoating inhibition. J Virol (2010) 0.88
Genomic Changes in an Attenuated ZB Strain of Foot-and-Mouth Disease Virus Serotype Asia1 and Comparison with Its Virulent Parental Strain. Int J Genomics (2014) 0.88
Inclusion of a specific T cell epitope increases the protection conferred against foot-and-mouth disease virus in pigs by a linear peptide containing an immunodominant B cell site. Virol J (2012) 0.81
Internalization of swine vesicular disease virus into cultured cells: a comparative study with foot-and-mouth disease virus. J Virol (2009) 0.81
Membrane topology and cellular dynamics of foot-and-mouth disease virus 3A protein. PLoS One (2014) 0.80
Lethal mutagenesis of foot-and-mouth disease virus involves shifts in sequence space. J Virol (2011) 0.78
Mutations that hamper dimerization of foot-and-mouth disease virus 3A protein are detrimental for infectivity. J Virol (2012) 0.78
Plasma membrane phosphatidylinositol 4,5 bisphosphate is required for internalization of foot-and-mouth disease virus and vesicular stomatitis virus. PLoS One (2012) 0.77
Laboratory animal models to study foot-and-mouth disease: a review with emphasis on natural and vaccine-induced immunity. J Gen Virol (2014) 0.76
Peptides Interfering 3A Protein Dimerization Decrease FMDV Multiplication. PLoS One (2015) 0.76
Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem (1987) 281.19
Rapid evolution of RNA genomes. Science (1982) 14.76
The three-dimensional structure of foot-and-mouth disease virus at 2.9 A resolution. Nature (1989) 5.87
Protection against foot-and-mouth disease by immunization with a chemically synthesized peptide predicted from the viral nucleotide sequence. Nature (1982) 5.50
The pathogenesis and diagnosis of foot-and-mouth disease. J Comp Pathol (2003) 3.83
Comparative genomics of foot-and-mouth disease virus. J Virol (2005) 3.42
Efficient infection of cells in culture by type O foot-and-mouth disease virus requires binding to cell surface heparan sulfate. J Virol (1996) 3.12
Multiple genetic variants arise in the course of replication of foot-and-mouth disease virus in cell culture. Virology (1983) 3.04
The origins of new pandemic viruses: the acquisition of new host ranges by canine parvovirus and influenza A viruses. Annu Rev Microbiol (2005) 2.89
Antibodies to the vitronectin receptor (integrin alpha V beta 3) inhibit binding and infection of foot-and-mouth disease virus to cultured cells. J Virol (1995) 2.66
Structure of a major immunogenic site on foot-and-mouth disease virus. Nature (1993) 2.55
Tissue culture adaptation of foot-and-mouth disease virus selects viruses that bind to heparin and are attenuated in cattle. J Virol (1997) 2.51
Nucleotide sequence heterogeneity of the RNA from a natural population of foot-and-mouth-disease virus. Gene (1980) 2.44
The structure and function of a foot-and-mouth disease virus-oligosaccharide receptor complex. EMBO J (1999) 2.28
The epithelial integrin alphavbeta6 is a receptor for foot-and-mouth disease virus. J Virol (2000) 2.24
Viruses as quasispecies: biological implications. Curr Top Microbiol Immunol (2006) 2.21
Host and virus determinants of picornavirus pathogenesis and tropism. Nat Rev Microbiol (2005) 2.15
Evolution of cell recognition by viruses. Science (2001) 2.14
Antibody recognition of picornaviruses and escape from neutralization: a structural view. Virus Res (1995) 2.13
Foot-and-mouth disease virus virulent for cattle utilizes the integrin alpha(v)beta3 as its receptor. J Virol (1998) 1.83
Picornavirus nonstructural proteins: emerging roles in virus replication and inhibition of host cell functions. J Virol (1993) 1.72
Function-blocking integrin alphavbeta6 monoclonal antibodies: distinct ligand-mimetic and nonligand-mimetic classes. J Biol Chem (2004) 1.72
Foot-and-mouth disease virus: a long known virus, but a current threat. Vet Res (2001) 1.70
Integrin alphavbeta1 is a receptor for foot-and-mouth disease virus. J Virol (2002) 1.60
Intracellular determinants of picornavirus replication. Trends Microbiol (1999) 1.60
A comparison of different methods of inoculating guinea-pigs with the virus of foot-and-mouth disease. J Comp Pathol Ther (1949) 1.58
Molecular basis of pathogenesis of FMDV. Virus Res (2003) 1.58
Foot-and-mouth disease virus mutant with decreased sensitivity to ribavirin: implications for error catastrophe. J Virol (2006) 1.56
The structure of a protein primer-polymerase complex in the initiation of genome replication. EMBO J (2006) 1.54
Multiple virulence determinants of foot-and-mouth disease virus in cell culture. J Virol (1998) 1.52
The pathogenesis of natural and simulated natural foot-and-mouth disease infection in cattle. J Comp Pathol (1981) 1.51
ANTIBODIES PRODUCED BY GUINEA PIGS INFECTED WITH FOOT-AND-MOUTH DISEASE VIRUS. J Immunol (1965) 1.51
Inhibition of cellular protein secretion by picornaviral 3A proteins. Virology (2005) 1.47
Genetic determinants of altered virulence of Taiwanese foot-and-mouth disease virus. J Virol (2000) 1.44
Vaccination: a management tool in veterinary medicine. Vet J (2002) 1.44
Extensive antigenic heterogeneity of foot-and-mouth disease virus of serotype C. Virology (1988) 1.42
Translation and replication of FMDV RNA. Curr Top Microbiol Immunol (2005) 1.42
Definition of an unexpected ligand recognition motif for alphav beta6 integrin. J Biol Chem (1999) 1.38
Integrin alphavbeta8 functions as a receptor for foot-and-mouth disease virus: role of the beta-chain cytodomain in integrin-mediated infection. J Virol (2004) 1.36
A large-scale evaluation of peptide vaccines against foot-and-mouth disease: lack of solid protection in cattle and isolation of escape mutants. J Virol (1997) 1.36
Structure and receptor binding. Virus Res (2003) 1.34
Systematic replacement of amino acid residues within an Arg-Gly-Asp-containing loop of foot-and-mouth disease virus and effect on cell recognition. J Biol Chem (1996) 1.33
Cell recognition by foot-and-mouth disease virus that lacks the RGD integrin-binding motif: flexibility in aphthovirus receptor usage. J Virol (2000) 1.32
Genomic nucleotide sequence of a foot-and-mouth disease virus clone and its persistent derivatives. Implications for the evolution of viral quasispecies during a persistent infection. Virus Res (1999) 1.31
Factors required for the Uridylylation of the foot-and-mouth disease virus 3B1, 3B2, and 3B3 peptides by the RNA-dependent RNA polymerase (3Dpol) in vitro. J Virol (2005) 1.29
A single amino acid substitution in nonstructural protein 3A can mediate adaptation of foot-and-mouth disease virus to the guinea pig. J Virol (2001) 1.29
Role of nonstructural proteins 3A and 3B in host range and pathogenicity of foot-and-mouth disease virus. J Virol (2003) 1.27
The non-structural polyprotein 3ABC of foot-and-mouth disease virus as a diagnostic antigen in ELISA to differentiate infected from vaccinated cattle. Arch Virol (1997) 1.27
Amino acid changes in proteins 2B and 3A mediate rhinovirus type 39 growth in mouse cells. J Virol (2005) 1.25
Genetic analysis of poliovirus protein 3A: characterization of a non-cytopathic mutant virus defective in killing Vero cells. J Gen Virol (1998) 1.22
Early events in integrin alphavbeta6-mediated cell entry of foot-and-mouth disease virus. J Virol (2005) 1.21
Structure of the complex of an Fab fragment of a neutralizing antibody with foot-and-mouth disease virus: positioning of a highly mobile antigenic loop. EMBO J (1997) 1.20
The alpha(v)beta6 integrin receptor for Foot-and-mouth disease virus is expressed constitutively on the epithelial cells targeted in cattle. J Gen Virol (2005) 1.20
Subcellular distribution of the foot-and-mouth disease virus 3A protein in cells infected with viruses encoding wild-type and bovine-attenuated forms of 3A. Virology (2001) 1.19
Structure-function analysis of Arg-Gly-Asp helix motifs in alpha v beta 6 integrin ligands. J Biol Chem (2007) 1.18
Specificity of the VP1 GH loop of Foot-and-Mouth Disease virus for alphav integrins. J Virol (2006) 1.16
Foot-and-mouth disease virus receptors: comparison of bovine alpha(V) integrin utilization by type A and O viruses. J Virol (2003) 1.11
VPg gene amplification correlates with infective particle formation in foot-and-mouth disease virus. J Virol (1992) 1.10
Analysis of a foot-and-mouth disease virus type A24 isolate containing an SGD receptor recognition site in vitro and its pathogenesis in cattle. J Virol (2005) 1.04
Foot-and-mouth disease virus replication sites form next to the nucleus and close to the Golgi apparatus, but exclude marker proteins associated with host membrane compartments. J Gen Virol (2005) 1.03
Identification of a nucleotide deletion in parts of polypeptide 3A in two independent attenuated aphthovirus strains. Virology (1990) 1.02
A similar pattern of interaction for different antibodies with a major antigenic site of foot-and-mouth disease virus: implications for intratypic antigenic variation. J Virol (1998) 1.01
Differential distribution of non-structural proteins of foot-and-mouth disease virus in BHK-21 cells. Virology (2006) 0.99
Genetic and phenotypic variability during replication of foot-and-mouth disease virus in swine. Virology (1990) 0.96
Immunity to foot-and-mouth disease virus in guinea pigs: clinical and immune responses. Infect Immun (1979) 0.96
Flexibility of the major antigenic loop of foot-and-mouth disease virus bound to a Fab fragment of a neutralising antibody: structure and neutralisation. Virology (1999) 0.96
Immunogenicity and T cell recognition in swine of foot-and-mouth disease virus polymerase 3D. Virology (2004) 0.95
Evolution of cell recognition by viruses: a source of biological novelty with medical implications. Adv Virus Res (2003) 0.92
Evidence of the coevolution of antigenicity and host cell tropism of foot-and-mouth disease virus in vivo. J Virol (2003) 0.90
Recovery of infectious foot-and-mouth disease virus from suckling mice after direct inoculation with in vitro-transcribed RNA. J Virol (2003) 0.87
The structure of an immunodominant loop on foot and mouth disease virus, serotype O1, determined under reducing conditions. Arch Virol Suppl (1994) 0.87
Differentiating infection from vaccination in foot-and-mouth-disease: evaluation of an ELISA based on recombinant 3ABC. Vet Microbiol (2004) 0.83
Biological and biomedical implications of the co-evolution of pathogens and their hosts. Nat Genet (2002) 4.42
Structure of foot-and-mouth disease virus RNA-dependent RNA polymerase and its complex with a template-primer RNA. J Biol Chem (2004) 2.48
Clinical characteristics of a large cohort of patients with scleritis and episcleritis. Ophthalmology (2011) 1.85
Lethal mutagenesis of the prototypic arenavirus lymphocytic choriomeningitis virus (LCMV). Virology (2003) 1.76
Suppression of viral infectivity through lethal defection. Proc Natl Acad Sci U S A (2005) 1.62
Evolutionary transition toward defective RNAs that are infectious by complementation. J Virol (2004) 1.61
Mutagenesis versus inhibition in the efficiency of extinction of foot-and-mouth disease virus. J Virol (2003) 1.58
Evolution of foot-and-mouth disease virus. Virus Res (2003) 1.57
Effect of alternating passage on adaptation of sindbis virus to vertebrate and invertebrate cells. J Virol (2005) 1.57
Foot-and-mouth disease virus mutant with decreased sensitivity to ribavirin: implications for error catastrophe. J Virol (2006) 1.56
The structure of a protein primer-polymerase complex in the initiation of genome replication. EMBO J (2006) 1.54
The dark side of the Sun. Nature (2006) 1.44
Curing of foot-and-mouth disease virus from persistently infected cells by ribavirin involves enhanced mutagenesis. Virology (2003) 1.44
Cell identity regulators link development and stress responses in the Arabidopsis root. Dev Cell (2011) 1.42
Sequential structures provide insights into the fidelity of RNA replication. Proc Natl Acad Sci U S A (2007) 1.37
Integrin alphavbeta8 functions as a receptor for foot-and-mouth disease virus: role of the beta-chain cytodomain in integrin-mediated infection. J Virol (2004) 1.36
Phase and antigenic variation in mycoplasmas. Future Microbiol (2010) 1.36
Foot-and-mouth disease virus. Comp Immunol Microbiol Infect Dis (2002) 1.33
High mutation rates, bottlenecks, and robustness of RNA viral quasispecies. Gene (2005) 1.31
Resistance of virus to extinction on bottleneck passages: study of a decaying and fluctuating pattern of fitness loss. Proc Natl Acad Sci U S A (2003) 1.27
Preextinction viral RNA can interfere with infectivity. J Virol (2004) 1.26
Structural insights into replication initiation and elongation processes by the FMDV RNA-dependent RNA polymerase. Curr Opin Struct Biol (2009) 1.22
Early events in integrin alphavbeta6-mediated cell entry of foot-and-mouth disease virus. J Virol (2005) 1.21
Stimulators of AMP-activated protein kinase inhibit the respiratory burst in human neutrophils. FEBS Lett (2004) 1.20
The alpha(v)beta6 integrin receptor for Foot-and-mouth disease virus is expressed constitutively on the epithelial cells targeted in cattle. J Gen Virol (2005) 1.20
Duration and fitness dependence of quasispecies memory. J Mol Biol (2002) 1.18
Rational engineering of recombinant picornavirus capsids to produce safe, protective vaccine antigen. PLoS Pathog (2013) 1.18
Insights into RNA virus mutant spectrum and lethal mutagenesis events: replicative interference and complementation by multiple point mutants. J Mol Biol (2007) 1.17
Integrin alpha v beta 6 is an RGD-dependent receptor for coxsackievirus A9. J Virol (2004) 1.16
The ultrastructure of the developing replication site in foot-and-mouth disease virus-infected BHK-38 cells. J Gen Virol (2004) 1.16
Specificity of the VP1 GH loop of Foot-and-Mouth Disease virus for alphav integrins. J Virol (2006) 1.16
Structure of Foot-and-mouth disease virus serotype A10 61 alone and complexed with oligosaccharide receptor: receptor conservation in the face of antigenic variation. J Gen Virol (2005) 1.14
Mutant viral polymerase in the transition of virus to error catastrophe identifies a critical site for RNA binding. J Mol Biol (2005) 1.13
A clathrin independent macropinocytosis-like entry mechanism used by bluetongue virus-1 during infection of BHK cells. PLoS One (2010) 1.11
Evidence for quasispecies distributions in the human hepatitis A virus genome. Virology (2003) 1.10
IRES-driven translation is stimulated separately by the FMDV 3'-NCR and poly(A) sequences. Nucleic Acids Res (2002) 1.09
A dominant-negative mutant of rab5 inhibits infection of cells by foot-and-mouth disease virus: implications for virus entry. J Virol (2009) 1.09
A multi-step process of viral adaptation to a mutagenic nucleoside analogue by modulation of transition types leads to extinction-escape. PLoS Pathog (2010) 1.08
Scleritis therapy. Ophthalmology (2011) 1.07
Hidden virulence determinants in a viral quasispecies in vivo. J Virol (2008) 1.06
Ultra-deep pyrosequencing detects conserved genomic sites and quantifies linkage of drug-resistant amino acid changes in the hepatitis B virus genome. PLoS One (2012) 1.06
Foot-and-mouth disease virus forms a highly stable, EDTA-resistant complex with its principal receptor, integrin alphavbeta6: implications for infectiousness. J Virol (2007) 1.06
Potential benefits of sequential inhibitor-mutagen treatments of RNA virus infections. PLoS Pathog (2009) 1.05
Wegener's granulomatosis. CMAJ (2008) 1.04
Murine norovirus-1 cell entry is mediated through a non-clathrin-, non-caveolae-, dynamin- and cholesterol-dependent pathway. J Gen Virol (2010) 1.04
Molecular basis for a lack of correlation between viral fitness and cell killing capacity. PLoS Pathog (2007) 1.04
Ribavirin can be mutagenic for arenaviruses. J Virol (2011) 1.03
Viral genome segmentation can result from a trade-off between genetic content and particle stability. PLoS Genet (2011) 1.03
Arenavirus genetic diversity and its biological implications. Infect Genet Evol (2009) 1.03
Emergence and selection of RNA virus variants: memory and extinction. Virus Res (2002) 1.02
Initial fitness recovery of HIV-1 is associated with quasispecies heterogeneity and can occur without modifications in the consensus sequence. PLoS One (2010) 1.02
Emergence of atypical Mycoplasma agalactiae strains harboring a new prophage and associated with an alpine wild ungulate mortality episode. Appl Environ Microbiol (2012) 1.01
Competition-colonization dynamics in an RNA virus. Proc Natl Acad Sci U S A (2010) 1.01
No evidence of selection for mutational robustness during lethal mutagenesis of lymphocytic choriomeningitis virus. Virology (2008) 1.01
Structure of foot-and-mouth disease virus mutant polymerases with reduced sensitivity to ribavirin. J Virol (2010) 1.01
15-deoxy-delta 12,14-prostaglandin J2 induces heme oxygenase-1 gene expression in a reactive oxygen species-dependent manner in human lymphocytes. J Biol Chem (2004) 1.00
Foot-and-mouth disease virus: biology and prospects for disease control. Microbes Infect (2002) 1.00
Dynamics of mutation and recombination in a replicating population of complementing, defective viral genomes. J Mol Biol (2006) 1.00
Productive entry of type C foot-and-mouth disease virus into susceptible cultured cells requires clathrin and is dependent on the presence of plasma membrane cholesterol. Virology (2007) 1.00
Differential distribution of non-structural proteins of foot-and-mouth disease virus in BHK-21 cells. Virology (2006) 0.99
Resistance to extinction of low fitness virus subjected to plaque-to-plaque transfers: diversification by mutation clustering. J Mol Biol (2002) 0.98
Quasispecies as a matter of fact: viruses and beyond. Virus Res (2011) 0.98
Acid-dependent viral entry. Virus Res (2012) 0.98
Capsid proteins from field strains of foot-and-mouth disease virus confer a pathogenic phenotype in cattle on an attenuated, cell-culture-adapted virus. J Gen Virol (2011) 0.98
Mutagenesis-induced, large fitness variations with an invariant arenavirus consensus genomic nucleotide sequence. J Virol (2005) 0.98
Enhanced mucosal immunoglobulin A response and solid protection against foot-and-mouth disease virus challenge induced by a novel dendrimeric peptide. J Virol (2008) 0.97
Expansion of host-cell tropism of foot-and-mouth disease virus despite replication in a constant environment. J Gen Virol (2004) 0.97
Pathways to extinction: beyond the error threshold. Philos Trans R Soc Lond B Biol Sci (2010) 0.97
Multidrug-resistant HIV-1 reverse transcriptase: involvement of ribonucleotide-dependent phosphorolysis in cross-resistance to nucleoside analogue inhibitors. J Mol Biol (2002) 0.96
nitric oxide triggers the phosphatidylinositol 3-kinase/Akt survival pathway in insulin-producing RINm5F cells by arousing Src to activate insulin receptor substrate-1. Endocrinology (2004) 0.96
Cell type-specific transcriptional profiling: implications for metabolite profiling. Plant J (2012) 0.96
Chromosomal transfers in mycoplasmas: when minimal genomes go mobile. MBio (2014) 0.95
Immunogenicity and T cell recognition in swine of foot-and-mouth disease virus polymerase 3D. Virology (2004) 0.95
Utility of recombinant integrin alpha v beta6 as a capture reagent in immunoassays for the diagnosis of foot-and-mouth disease. J Virol Methods (2005) 0.95
Counteracting quasispecies adaptability: extinction of a ribavirin-resistant virus mutant by an alternative mutagenic treatment. PLoS One (2009) 0.94
Genome-scale analysis of Mycoplasma agalactiae loci involved in interaction with host cells. PLoS One (2011) 0.94
Beneficial effects of population bottlenecks in an RNA virus evolving at increased error rate. J Mol Biol (2008) 0.93
Foot-and-mouth disease virus, but not bovine enterovirus, targets the host cell cytoskeleton via the nonstructural protein 3Cpro. J Virol (2008) 0.93
Complete alanine scanning of intersubunit interfaces in a foot-and-mouth disease virus capsid reveals critical contributions of many side chains to particle stability and viral function. J Biol Chem (2003) 0.93
Efficient production of foot-and-mouth disease virus empty capsids in insect cells following down regulation of 3C protease activity. J Virol Methods (2012) 0.92